Apoptosis Imaging with 18F-Ml-10 Micropet/Ct for Early Prediction of Response to Treatment in A Human Pancreatic Tumor Xenograft Model

Silong Hu,Ming-Wei Wang,Yu-Jia Zheng,Xiao Bao,Jianping Zhang,Yingjian Zhang,Zhengrong Zhou

2014-01-01

Journal of Nuclear Medicine

Abstract:1378 Objectives to evaluate the performance of microPET/CT with 18F-labeled 5-fluorpentyl-2-methyl-malonic acid (18F-ML-10) for the quantification of cell death induced by gemcitabine and radiation in a human pancreatic cancer xenograft mice model and early assessment of tumor response to therapy. Methods Nude mice bearing with human pancreatic carcinoma cell SW1990 were treated with gemcitabine or radiation. 18F-ML-10 microPET/CT scans were performed at 6h, 24h, 48h and 72h after chemotherapy and at 24h after radiotherapy. TUNEL staining of murine xenografts were performed to determine the apoptotic index (AI). Correlation analysis between tumor uptake (% Injected Dose per gram, %ID/g) of 18F-ML-10 and AI was performed. Results One dose of gemcitabine treatment induced a significant increase in tumor uptakes of 18F-ML-10 as early as 24h after treatment. The accumulations of 18F-ML-10 were visualized clearly by microPET/CT in local tumor at 24h, 48h and 72h after chemotherapy. Sustained increase of 18F-ML-10 uptake was observed until 72h after treatment and the AIs from TUNEL staining were consistent with microPET/CT imaging results. The differences of both %ID/g and AI among these groups were significant (P Conclusions 18F-ML-10 microPET/CT can visualize apoptosis induced by chemotherapy and radiotherapy in pancreatic cancer xenograft model as early as 24h after treatment. The optimal time window for the detection of apoptosis with 18F-ML-10 microPET/CT could be 72h after chemotherapy.